Posts

The Great Divide in Pakistan Pharma Market – Suggestions for Smaller Companies – Asrar Qureshi’s Blog Post #1321

Image
The Great Divide in Pakistan Pharma Market – Suggestions for Smaller Companies – Asrar Qureshi’s Blog Post #1321 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1321 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Shvets Production Preamble As shown in the last blog post, there is a great divide in the pharma market of Pakistan. I continuation with the previous blog post, here are some suggestions how smaller companies can get a decent foothold in the market. The Great Divide in Pakistan Pharma: How Smaller Companies Can Build a Respectable Foothold Pakistan's pharmaceutical market has a great divide. On one side are the large companies with substantial market shares, extensive product portfolios, strong distribution networks, large sales forces and well-established brands.On the other side are hundreds of smal...
Post a Comment
Read more

Pakistan Pharma Market – Uneven Distribution and Its Impact on Competition and Strategy – Asrar Qureshi’s Blog Post #1320

Image
Pakistan Pharma Market – Uneven Distribution and Its Impact on Competition and Strategy – Asrar Qureshi’s Blog Post #1320 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1320 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Elements Interactive Preamble A highly concentrated market creates winners, survivors, and a strategic problem for everyone else Pakistan's pharmaceutical market presents a fascinating paradox. On one side is an industry with hundreds of pharmaceutical companies, a large manufacturing base and a growing domestic demand for medicines. On the other is a market in which a relatively small number of companies capture the overwhelming majority of sales. Industry data has consistently shown this concentration. A 2023 VIS sector report estimated that the top 50 companies held nearly 90% of the marke...
Post a Comment
Read more

Why Should Childhood Cancer Survival Depend on Where the Child is Born? – Asrar Qureshi’s Blog Post #1319

Image
Why Should Childhood Cancer Survival Depend on Where the Child is Born? – Asrar Qureshi’s Blog Post #1319 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1319 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Pavel Danilyuk Preamble This post is based on a World Health Organization Report.. Link at the end. WHO’s 2026 report, Measuring survival, driving change: advancing equity through the WHO Global Initiative for Childhood Cancer, examines one of the most striking inequalities in global health: children with cancer can face dramatically different chances of survival depending on where they live. The report introduces comparable five-year survival estimates for lymphoid leukaemia across 194 Member States and links better data to stronger policy and health-system action. WHO’s global target is at least 60% childh...
Post a Comment
Read more

Women are Living Longer, But are they Living healthier? – Asrar Qureshi’s Blog Post #1318

Image
Women are Living Longer, But are they Living healthier? – Asrar Qureshi’s Blog Post #1318 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1318 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Yan Krukau Credit: Mikhail Nilov Credit: Nguyen Tien Thinh Preamble This post is based on recently published Boston Consulting Group research. Link at the end. The $350 Billion Question: Why Women’s Longevity Is the Next Big Healthcare Opportunity Women are living longer, but are they living healthier? That question may become one of the most important questions in healthcare over the next decade. Women generally live longer than men. Yet the additional years are not necessarily years of good health. According to Boston Consulting Group’s latest research on women and longevity, women spend a larger proportion of their lives...
Post a Comment
Read more

Turning Organizational Values into Everyday Behavior – Asrar Qureshi’s Blog Post #1317

Image
Turning Organizational Values into Everyday Behavior – Asrar Qureshi’s Blog Post #1317 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1317 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Hassan Zaheer Preamble This post is based on Harvard Business Review article. Link at the end. From Values to Action: How Leaders Make Principles Hold Under Pressure Part 2 of 2 — Turning Organizational Values into Everyday Behavior What happens to organizational values when following them becomes difficult? The answer determines whether values are merely corporate language or an actual part of organizational culture. Values do not become real simply because leadership declares them. They become real when they are embedded into the organization's decisions, systems, incentives, leadership behavior and consequences. In other wo...
Post a Comment
Read more

From Values on the Wall to Values Under Pressure – Asrar Qureshi’s Blog Post #1316

Image
From Values on the Wall to Values Under Pressure – Asrar Qureshi’s Blog Post #1316 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1316 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Walls.io Preamble This post is based on Harvard Business Review article. Link at the end. When Values Are Tested: What Does Your Organization Really Stand For? Part 1 of 2 –  From Values on the Wall to Values Under Pressure Every organization has values. They appear in annual reports, websites, employee handbooks, induction programs and conference-room walls. Integrity. Customer focus. Excellence. Respect. Innovation. Quality. Accountability. The words are usually attractive. Almost nobody argues with them. But there is a more important question: What happens to those values when following them becomes expensive, inconvenient...
Post a Comment
Read more

Manager Visibility is Not Enough for Leadership – Asrar Qureshi’s Blog Post #1315

Image
Manager Visibility is Not Enough for Leadership – Asrar Qureshi’s Blog Post #1315 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1315 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Gustavo Fring Preamble This post is based on Harvard Business School Professors Research. Link at the end. Walking the Floor Is Not Enough: Turning Management Visibility into Real Problem Solving Management books have long encouraged leaders to "walk the floor." The idea is simple and attractive: senior managers should leave their offices, visit the workplace, talk to employees, observe operations and discover problems firsthand. In pharmaceutical companies, this can mean a plant head walking through production, a sales director accompanying medical representatives, a commercial leader visiting distributors, a quality head ob...
Post a Comment
Read more